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Hepatitis E virus (HEV) is a common cause of acute hepatitis worldwide. 
Genotypes 1 and 2 are associated with waterborne transmission and 
faecal-oral spread, while genotypes 3 and 4 are associated with zoonotic 
transmission by meat from pigs and other animals.[1]
Early HEV seroprevalence studies in South Africa (SA) showed 
seroprevalence rates of 2.05% in Gauteng[2] and 10.7% in the Eastern 
and Western Cape provinces.[3] The latter study suggested waterborne 
transmission (odds ratio (OR) 2.85).[3] Recent studies in Cape Town 
(the Western Cape) reported HEV seroprevalence rates of 28% and 
26% in patients without liver disease attending clinics at teaching 
hospitals[1] and in blood donors,[4] respectively. Both studies showed an 
increase in seroprevalence with age.[1,4] Madden et al.[1] found an associa -
tion with eating pork (OR 1.93; 95% confidence interval (CI) 1.45 - 2.55) 
or bacon/ham (OR 1.50; 95% CI 1.14 - 1.98). Lopes et al.[4] showed that 
HEV seroprevalence did not correlate with hepatitis A seroprevalence, 
and had different age and socioeconomic associations, suggesting an 
infection route other than waterborne transmission.[4] HEV-3 circulates 
in humans and animals in SA. Three human cases of HEV-3 have been 
reported in Cape Town.[1,5,6] Two studies reported circulation of HEV-3 
in pigs in the Eastern and Western Cape.[7,8]
We investigated evidence of HEV infection in hospitalised patients 
with acute hepatitis at Groote Schuur Hospital, Cape Town.
Methods
Over a 60-day period, serum specimens submitted to the diagnostic 
laboratory at the National Health Laboratory Service, Groote Schuur 
Hospital, were identified with raised transaminases, negative serology 
for acute hepatitis A, B and C, and no other identifiable cause in 
further investigations on the patients of origin. Results for all serum 
specimens tested serologically for hepatitis A, B and C were extracted 
from the laboratory information system (N=2 970). Only those that 
tested negative for all three infections were selected (n=552), and were 
narrowed down to specimens with raised aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) (n=478). Additional labo-
ratory samples were screened for other identified causes, leaving 
391 without a known cause. Finally, 164 with sufficient specimen 
remaining (550 µL) were included in the study.
All specimens were tested by reverse transcription polymerase chain 
reaction (PCR) capable of detecting all 4 relevant genotypes, and by 
enzyme-linked immunosorbent assay (ELISA). IgM and IgG ELISAs 
were performed using Fortress Diagnostics HEV-IgM and HEV-IgG 
ELISA kits (Fortress Diagnostics, UK) as per manufacturer’s protocol. 
For molecular detection, nucleic acid from 500 µL serum was eluted 
into 50 µL using Nuclisens EasyMag (bioMerieux, the Netherlands). One-
step reverse transcription PCR was performed with 10 µL nucleic acid 
eluate using SuperScript One-Step RT-PCR System with Platinum Taq 
(Thermo Fisher Scientific, USA) in 50 µL final volume. Nested PCR 
was performed with 2 µL prenested amplicon in 50 µL final volume 
using SuperTherm Taq DNA Polymerase (Separation Scientific, South 
Africa). Primers (forward outer 3156, reverse outer 3157, forward 
inner 3158, reverse inner 3159) and cycling conditions were as 
described by Meng et al.[9] Products (348 base pairs) were viewed under 
ultraviolet light on 2% agarose gel.
Ethical approval
The study was approved by the Human Research Ethics Committee 
of the University of Cape Town (ref. no. 074/2012).
Results
Patient demographics in the laboratory information system were 
limited. Age of participants ranged from 3 to 88 (median 34) years. 
Eighty-nine participants were females and 75 were males.
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Background. Early hepatitis E virus (HEV) seroprevalence studies in South Africa (SA) showed seroprevalence rates of 2 - 10%, and 
suggested waterborne transmission. More recent studies in Cape Town, SA, reported HEV seroprevalence rates of 28% and 26% in 
outpatients without liver disease and blood donors, respectively. An association was found with eating pork or bacon/ham. Only 3 human 
cases of hepatitis E in SA have been reported in the literature.
Objectives. To find evidence of HEV infection in hospitalised patients with acute hepatitis and no other identified cause.
Methods. Leftover serum samples were retrieved for patients negative for hepatitis viruses A, B and C, where no other cause of hepatitis was 
identified. Samples were tested for HEV by polymerase chain reaction (PCR) and IgM and IgG enzyme-linked immunosorbent assay (ELISA).
Results. Anti-HEV IgG was detected in 39/132 specimens (29.5%; 95% confidence interval (CI) 22.4 - 37.8), and anti-HEV IgM in 2/125 speci -
mens (1.6%; 95% CI 0.4 - 5.7). No specimen tested positive by PCR.
Conclusions. IgG seroprevalence found in this study was similar to that previously reported in Cape Town. IgM positivity in 2 patients 
was not confirmed by PCR. Locally, hepatitis E may not be a common cause of clinically apparent hepatitis that requires hospitalisation.
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The test results are shown in Table 1. Anti-HEV IgG was detected in 
39/132 specimens (29.5%; 95% CI 22.4 - 37.8), and anti-HEV IgM in 
2/125 specimens (1.6%; 95% CI 0.4 - 5.7), both of which were also 
IgG positive. Both positive IgM results were near the cut-off (optical 
densities: 0.651 and 0.283; both below the 2.5 times cut-off optical 
density of 0.268), suggesting possible nonspecific ELISA reactivity. 
Fig. 1 shows the IgG seroprevalence curve for participants with 
known ages. No specimen tested positive by PCR.
Discussion
This study was the first to investigate HEV infection in patients with 
acute hepatitis in SA. IgG seroprevalence (29%) found in this study 
was similar to IgG seroprevalence rates reported in Cape Town.[1,4] 
Although the sample size was small, the same trend of increasing 
seroprevalence with age, with a significant increase in patients >30 years, 
can be seen, as in the larger study on patients without liver disease 
(Fig. 1).[1] The anomalous higher seroprevalence in patients ˂20 years 
of age may be an artefact due to the small sample sizes being compared. 
The lack of PCR-confirmed acute hepatitis E in this study may be 
due to selection bias, as HEV often causes a mild illness, with most 
patients not requiring blood tests to investigate clinically apparent 
acute hepatitis. The 2 IgM low-positive specimens in this study 
may reflect acute HEV infection after clearance of viraemia, but 
may also reflect the known nonspecificity problems of IgM assays 
in populations of ill, hospitalised patients.[10] The sensitivity and 
specificity for the IgM kit used are reported in the package insert as 
97.1% and 100%, respectively. 
Study limitations
The main limitation of this study is specimen selection bias, as we 
only investigated patients tested for hepatitis A, B and C. We did 
not investigate HEV co-infection with other hepatitis viruses. Other 
limitations and potential biases include sampling of only public 
healthcare-sector patients, sample size and lack of patient follow-up 
by researchers. The findings in this study may not apply to other 
provinces, which may have a different HEV epidemiology.
Conclusions
HEV is present in the Western Cape, and is associated with consump-
tion of food derived from pig meat;[1] however, locally it may not be a 
common cause of clinically apparent hepatitis that requires hospitali-
sation. Further studies aimed at detecting acute HEV infection, both 
severe and mild, are warranted to elucidate the clinical picture of 
HEV infection in the Western Cape and SA.
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Table 1. Hepatitis E serology and PCR results
Results Anti-HEV IgG Anti-HEV IgM HEV PCR
Positive 39 (29.5%) 2* (1.6%) 0
Negative 93 123 164
Total 132† 125† 164
PCR = polymerase chain reaction; HEV = hepatitis E virus. 
*Both IgM-positive samples were also positive for IgG.
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Fig. 1. Hepatitis E IgG seroprevalence by age for participants with a recorded 
age. Number of positive samples per age group is shown, with total number 
of samples per age group, and the seroprevalence percentage. (HEV = hepatitis E 
virus.)
